[Diabetic cardiomyopathy: concept, heart function, and pathogenesis]

P Codinach Huix1, R Freixa Pamias

  • 1Servicio de Cardiología, Hospital de la Creu Roja, C/Dos de Maig, 301, 08025 Barcelona.

Anales De Medicina Interna (Madrid, Spain : 1984)
|August 3, 2002
PubMed

Insights

Diabetic cardiomyopathy, a heart condition linked to diabetes, involves left ventricular dysfunction. While often associated with other conditions, it can occur solely due to diabetes, particularly in younger patients.

Area of Science:

  • Cardiology and Endocrinology
  • Pathophysiology of Diabetes

Context:

  • Diabetic cardiomyopathy is a distinct cardiac condition arising from diabetes.
  • It is characterized by left ventricular diastolic and/or systolic dysfunction.
  • Diabetes can induce metabolic alterations, fibrosis, hypertrophy, and microvascular changes contributing to cardiomyopathy.

Purpose:

  • To define diabetic cardiomyopathy and its underlying mechanisms.
  • To differentiate diabetic cardiomyopathy from other cardiac conditions often comorbid with diabetes.
  • To explore the potential for diabetes as the sole cause of myocardial disease.

Summary:

  • Diabetic cardiomyopathy presents with ventricular dysfunction, potentially caused by diabetes-induced metabolic, structural, and autonomic changes.
  • Exclusion of comorbidities like hypertension and coronary artery disease is crucial for diagnosis.
  • Subclinical dysfunction in asymptomatic diabetics suggests diabetes as a primary etiological factor, though further research on its natural history is needed.

Impact:

  • Highlights the independent role of diabetes in causing heart muscle disease.
  • Emphasizes the need for early detection and management of cardiac issues in diabetic patients.
  • Underscores the necessity for continued research into the long-term progression and outcomes of diabetic cardiomyopathy.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...